- Disease: Acute SARS-CoV-2
- Study type: Observational Cohort Study
- Study type descriptors: Retrospective, Single centre
- Study aim: To evaluate the overall tolerability and safety of molnupiravir and nirmatrelvir/ritonavir in a real life setting by retrospectively assessing the proportions and type of adverse events detected in clinical practice
- Number of participants enrolled: 909
- Study enrolling from to
- Study includes follow-up for 30 days
Study Data
- Adults
- Elderly
- General population
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Molnupiravir
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to